Table 2.
Multivariate Cox regression analysis of the 23‐mRNA‐based prognostic model and clinical features associated with OS of SHH MB patients. LC/A, large cell/anaplastic; MBEN, medulloblastoma with extensive nodularity
| Variables | HR (95% CI) | P |
|---|---|---|
| Age | ||
| Increasing years | 1.00 (0.97–1.04) | 0.858 |
| Gender | ||
| Male vs female | 0.51 (0.23–1.12) | 0.095 |
| Histology | ||
| Desmoplastic vs classic | 0.31 (0.10–0.98) | 0.046 |
| LC/A vs classic | 0.45 (0.16–1.25) | 0.123 |
| MBEN vs classic | 0.00 (0–Inf) | 0.997 |
| Metastatic status | ||
| Metastatic vs nonmetastatic | 3.40 (1.36–8.48) | 0.009 |
| 23‐mRNA‐based prognostic model | ||
| Increasing risk scores | 1.80 (1.45–2.24) | 1.10E‐07 |